Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024-Reference-Cited by-同舟云学术

Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024

Published:2024-06-13 Issue:24 Volume:29 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Nordholm Anne Christine¹^ORCID,Trier Møller Frederik¹^ORCID,Fischer Ravn Signe²,Flink Sørensen Lotte²,Moltke-Prehn Anja²^ORCID,Elskær Mollerup Jacob²,Funk Tjede¹^ORCID,Sperling Lene³,Jeyaratnam Ulisa¹,Træholt Franck Kristina⁴^ORCID,Hjort-Pedersen Karina³,Hjørnet Kamper Christina⁵,Thoft Nielsen Rikke²,Jokelainen Pikka⁶^ORCID,Wessman Maria¹^ORCID

Affiliation:

1. Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark

2. Department of Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark

3. Department of Gynaecology and Obstetrics, Odense University Hospital, Odense, Denmark

4. Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark

5. Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark

6. Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark

Abstract

We report an epidemic of parvovirus B19 infections in Denmark during the first quarter of 2024, with a peak incidence 3.5 times higher than during the most recent epidemic in 2017. In total, 20.1% (130/648) of laboratory-confirmed cases were pregnant. Severe adverse outcomes were observed among 12.3% (16/130) of pregnant people and included foetal anaemia, foetal hydrops and miscarriage. Parvovirus B19 infection is not systematically monitored, but a national laboratory-based surveillance system is currently being established in Denmark.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Reference16 articles.

1. Frequency of human parvovirus B19 infection in intrauterine fetal death.;Tolfvenstam;Lancet,2001

2. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.;Mossong;Epidemiol Infect,2008

3. Risk factors for parvovirus B19 infection in pregnancy.;Valeur-Jensen;JAMA,1999

4. Statens Serum Institut (SSI). Parvovirus B19 and pregnancy. Epi-News, no. 13 2024. Copenhagen: SSI; 10 Apr 2024. Available from: https://en.ssi.dk/news/epi-news/2024/no-13---2024

5. Parvovirus B19 and the pathogenesis of anaemia.;Chisaka;Rev Med Virol,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Universal serological screening for Parvovirus B19 in pregnancy during European epidemic;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. Clinical impact of recent surge in acute parvovirus B19 infections in Leicester UK, March–July 2024;Journal of Medical Virology;2024-09

3. Impact of parvovirus B19 outbreak in a single center;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

4. Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence;Viruses;2024-08-24

5. Prenatal parvovirus B19 infection;Archives of Gynecology and Obstetrics;2024-07-29